Evidence map›Paper›PMID 31924781›Full record

ArticleNature communications2020

Neutrophil microvesicles drive atherosclerosis by delivering miR-155 to atheroprone endothelium.

Ingrid Gomez, Ben Ward, Celine Souilhol, Chiara Recarti, Mark Ariaans, Jessica Johnston, Amanda Burnett, Marwa Mahmoud, Le Anh Luong, Laura West and 14 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 112 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
112citing papers in PubMed, 1 pooled it
8.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

112 citing papers in PubMed, 1 synthesis or guideline pooled it, 153 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. [Neutrophil-derived Microvesicles Regulate DNA Methylation of theSichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2026
    Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review

52 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 8 institutions in 4 countries.

Ingrid GomezDepartment of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Ben WardDepartment of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Celine SouilholDepartment of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Chiara RecartiDepartment of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Mark AriaansDepartment of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.ORCID http://orcid.org/0000-0002-7392-8278
Jessica JohnstonDepartment of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.ORCID http://orcid.org/0000-0003-4877-0680
Amanda BurnettDepartment of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Marwa MahmoudDepartment of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Le Anh LuongWilliam Harvey Research Institute, Queen Mary University, London, UK.
Laura WestDepartment of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.ORCID http://orcid.org/0000-0003-2953-2521
Merete LongDepartment of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Sion ParrySchool of Sport, Exercise and Health Sciences, Loughborough University, Loughborough, UK.
Rachel WoodsSchool of Sport, Exercise and Health Sciences, Loughborough University, Loughborough, UK.ORCID http://orcid.org/0000-0003-4524-5346
Carl HulstonSchool of Sport, Exercise and Health Sciences, Loughborough University, Loughborough, UK.ORCID http://orcid.org/0000-0002-5375-1161
Birke BenedikterDepartment of Medical Microbiology, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, The Netherlands.ORCID http://orcid.org/0000-0002-1103-2484
Chiara NiespoloDepartment of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Rohit BazazDepartment of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Sheila FrancisDepartment of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.ORCID http://orcid.org/0000-0001-6552-0339
Endre Kiss-TothDepartment of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.ORCID http://orcid.org/0000-0003-4406-4017
Marc van ZandvoortDepartment of Molecular Cell Biology, CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.
Andreas SchoberExperimental Vascular Medicine, Ludwig-Maximilian University of Munich, Munich, Germany.ORCID http://orcid.org/0000-0001-7798-136X
Paul HellewellDepartment of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.ORCID http://orcid.org/0000-0002-2044-1570
Paul C EvansDepartment of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Victoria RidgerDepartment of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK. V.C.Ridger@Sheffield.ac.uk.ORCID http://orcid.org/0000-0003-4163-669X
University of Sheffield · GBInsigneo · GBLoughborough University · GBMaastricht University · NLBrunel University of London · GBEmory University · USLudwig-Maximilians-Universität München · DEWilliam Harvey Research Institute · GB

Funding

British Heart Foundation FS/14/8/30605British Heart Foundation PG/13/55/30365British Heart Foundation PG/14/38/30862British Heart Foundation PG/16/44/32146British Heart Foundation RG/19/10/34506British Heart Foundation (BHF) FS/14/8/30605British Heart Foundation (BHF) PG/09/067/27901British Heart Foundation (BHF) PG/13/55/30365British Heart Foundation (BHF) PG/14/38/30862British Heart Foundation (BHF) PG/14/8/30605British Heart Foundation (BHF) PG/16/44/32146Medical Research Council MR/K023977/1
6 · The paper itself

Abstract

Neutrophils are implicated in the pathogenesis of atherosclerosis but are seldom detected in atherosclerotic plaques. We investigated whether neutrophil-derived microvesicles may influence arterial pathophysiology. Here we report that levels of circulating neutrophil microvesicles are enhanced by exposure to a high fat diet, a known risk factor for atherosclerosis. Neutrophil microvesicles accumulate at disease-prone regions of arteries exposed to disturbed flow patterns, and promote vascular inflammation and atherosclerosis in a murine model. Using cultured endothelial cells exposed to disturbed flow, we demonstrate that neutrophil microvesicles promote inflammatory gene expression by delivering miR-155, enhancing NF-κB activation. Similarly, neutrophil microvesicles increase miR-155 and enhance NF-κB at disease-prone sites of disturbed flow in vivo. Enhancement of atherosclerotic plaque formation and increase in macrophage content by neutrophil microvesicles is dependent on miR-155. We conclude that neutrophils contribute to vascular inflammation and atherogenesis through delivery of microvesicles carrying miR-155 to disease-prone regions.

Indexed as

AnimalsAtherosclerosisDiet, High-FatDisease Models, AnimalEndothelial CellsEndotheliumGene Expression RegulationHumansMacrophagesMiceMice, Knockout, ApoEMicroRNAsNeutrophilsNF-kappa BPlaque, AtheroscleroticMicroRNAsMirn155 microRNA, mouseNF-kappa B

Identifiers

PMID31924781
PMCPMC6954269
OpenAlexW3000013851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.